Manufacturer record

Dexibo Pharma Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Dexibo Pharma Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between June 2025 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: DPT-2882, Aceclofenac, Paracetamol Chlorzoxazone Tablets (Nimal-MR) (exp Feb 2026). DTL, Puducherry (state lab) found it not of standard quality: Failed in Description. Listed in the October 2025 alert.

Records by type

2 records linked to Dexibo Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jun 2025 to Oct 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Disintegration
Most common failure
Oct 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Aceclofenac, Paracetamol Chlorzoxazone Tablets (Nimal-MR) Batch DPT-2882Mfg Mar 2024 · Exp Feb 2026 Failed in DescriptionDescription DTL, PuducherryState lab Oct 2025
Paracetamol, Phenylphrine HCL, CPM & Caffeine Tablets (Goco-Plus) Batch DPT-1223Mfg Sep 2024 · Exp Aug 2026 DisintegrationDisintegration State Lab PuducherryState lab Jun 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.